NORITNIELSEN ApS PHARMASOURCE: Financial statements 2017
CVR: 33266707
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
NORITNIELSEN ApS PHARMASOURCE (CVR 33266707) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,522,829 and a net result of DKK 855,133 compared with DKK 1,451,797 the year before. That is a decrease of 24.6% compared with the year before. Equity in the 2017 report amounted to DKK 1,908,593. The solvency ratio was 68.6%.
- Gross Profit
- DKK 2,522,829
- Profit/Loss
- DKK 855,133
- Equity
- DKK 1,908,593
- Total Assets
- DKK 2,783,836
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 2.5M | 855K | 1.9M | - |
| 2016 | - | 3.3M | 1.5M | 2.3M | - |
| 2015 | - | 3M | 1.2M | 1.8M | - |
| 2014 | - | 3.2M | 630K | 1.1M | - |
| 2013 | - | 3.4M | 771K | 997K | - |
Official annual report
Keep an eye on NORITNIELSEN ApS PHARMASOURCE
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout NORITNIELSEN ApS PHARMASOURCE
NORITNIELSEN ApS PHARMASOURCE was a Danish company of the type Anpartsselskab based in Farum, founded in 2010. The company has been dissolved on 1 May 2025. The company was registered under the industry Virksomhedsrådgivning og andre rådgivningsaktiviteter. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 374,773 and a net result of DKK 22,170 compared with DKK 77,974 the year before. Equity in the 2024 report amounted to DKK 180,144.